BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CASL - Canadian Association for the Study of the Liver - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CASL - Canadian Association for the Study of the Liver
X-ORIGINAL-URL:https://hepatology.ca/fr
X-WR-CALDESC:Événements pour CASL - Canadian Association for the Study of the Liver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240503
DTEND;VALUE=DATE:20240505
DTSTAMP:20260417T114620
CREATED:20240218T204323Z
LAST-MODIFIED:20240218T204323Z
UID:3488-1714694400-1714867199@hepatology.ca
SUMMARY:Innovations in SLD Think-Tank 2024
DESCRIPTION:This 2-day program will provide an interactive platform for endocrinologists\, gastroenterologist hepatologists\, primary care physicians\, and associated health care professionals (PAs\, nurses) working in the field of SLD. Outmost goal is to allow knowledge exchange on MASLD beyond the hepatology arena and among all levels of expertise. \n \nThe new format will employ the Wilton Park style in which we intend to have panel discussions around hot topics in order to generate ideas and provide insights and recommendations: \n\nBridging the Diagnostics Gap\nPrevention is the ‘Cure’ Hidden in Plain Sight\nThe Future of Treatments Now\nMaking Ready Our World Unready\nTargeting Investments for Social and Economic Returns\nthe Role of Social Media in MASLD Education\nOpen Science Session on MASLD\n\nEach of the topics will be introduced by a short lecture highlighting the issue and kick-starting the discussion. After a focused discussion among the panel members\, the discussion is opened to the audience ensuring an informal and interactive setting to discuss audience-proposed topics. \nRegister for SLD Think-Tank 2024 \nIn addition\, the SLD Think-Tank will accept abstract submissions and look forward to inviting the key contributors to take part in the relevant panel discussions. \nAbstract Deadline: Friday\, 1 March 2024 at 23:59 CET \nAbstract Submission Link: https://virology.eventsair.com/sld2024/abstracts \n \n 
URL:https://hepatology.ca/fr/event/innovations-in-sld-think-tank-2024/
CATEGORIES:In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240509T080000
DTEND;TZID=UTC:20240509T170000
DTSTAMP:20260417T114620
CREATED:20240428T160326Z
LAST-MODIFIED:20240508T194153Z
UID:3553-1715241600-1715274000@hepatology.ca
SUMMARY:Canadian Viral Hepatitis Elimination Day
DESCRIPTION:On Thursday\, May 9\, 2024\, the Canadian Association for the Study of the Liver will join Action Hepatitis Canada\, CanHepC\, CanHepB\, and the Canadian Liver Foundation to mark the 3rd annual Canadian Viral Hepatitis Elimination Day in Ottawa. \n#CanHepDay24  #HepCantWait \nThank you to our many members and allies who are helping amplify our call for the federal government\, as well as each province and territory\, to bring urgency to eliminating viral hepatitis as a public health threat in Canada by 2030. \nFIVE FEDERAL ASKS \nIn 2016\, Canada made an international commitment to eliminate viral hepatitis as a public health threat by 2030. While much of this work falls to the provinces and territories\, there are five key things the federal government can do now. \n1. Planning: Add targets to measure progress in eliminating viral hepatitis to the 2025-2030 STBBI Action Plan.\nAn updated federal STBBI Action Plan was launched in January 2024. The plan excludes targets to measure Canada’s progress and inform federally funded projects. Targets are integral to an elimination plan. \n2. Testing: Update hepatitis C screening guidelines to be evidence-based\, develop evidence-based screening guidelines for hepatitis B\, and start offering free\, voluntary STBBI testing and linkage to care for all immigrants and newcomers.\nCanada’s hepatitis C screening guidelines recommend only screening people with certain risk factors\, despite all evidence that risk-based screening guidelines are ineffective at identifying chronic hepatitis C infections in time to avoid advanced liver disease or death. Canada does not have national hepatitis B screening guidelines at all\, resulting in many people being diagnosed at the same time they receive their liver cancer diagnosis. \n3. Testing-to-Treatment Link: Engage manufacturers of point-of-care testing technologies to bring these tests to Canada.\nHepatitis C is curable and hepatitis B is treatable. It takes several appointments to proceed from initial screening to starting treatment\, in part because point-of-care confirmatory testing technology used in other parts of the world is not yet available in Canada.\n​\n4. Prevention: Update NACI guidelines to recommend universal birth-dose hepatitis B vaccination.\nHepatitis B is vaccine-preventable. Canada is out of step with the WHO’s recommendation that even regions with low incidence of hepatitis B provide universal birth dose vaccination. Five provinces still offer the first publicly-funded doses of hepatitis B vaccine in school-based programs for ages 9-12\, which have a vaccination rate of ~70%\, missing the 90% WHO target. \n5. Data: Fund and increase efforts to collect updated hepatitis B and C prevalence estimates and population-specific cascades of care for all Canadian provinces and territories.\nIn order to measure our progress in viral hepatitis elimination\, we need reliable\, fulsome data about how many people are affected. \n\n\n\n\n\n\nSocial Media Graphics for Sharing\n\n\n\n\n\n\nThese graphics can be shared on social media with your own message and the hashtags #HepCantWait and #CanHepDay24.\n\n \n\n\nClick on the image to save it\n \n\nClick on the image to save it
URL:https://hepatology.ca/fr/event/canadian-viral-hepatitis-elimination-day/
LOCATION:Ottawa\, Canada
CATEGORIES:Endorsed by CASL,In-Person
END:VEVENT
END:VCALENDAR